SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-021090
Filing Date
2014-04-07
Accepted
2014-04-07 12:03:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 RULE 424(B)(3) v373725_424b3.htm 424B3 664375
  Complete submission text file 0001144204-14-021090.txt   665448
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-191880 | Film No.: 14747924
SIC: 2834 Pharmaceutical Preparations